SLS · Company research
SELLAS Life Sciences Group, Inc. (SLS): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
23records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| SLS Stock Jumps Overnight: Retail Eyes Huge Potential Buyout As CEO Marks 15 Years - Stocktwits | SLS Stock Jumps Overnight: Retail Eyes Huge Potential Buyout As CEO Marks 15 Years Stocktwits | View source ↗ | Stocktwits | Oct 20, 2026 | neutral | 0 | 0.6 |
| SLS Stock Climbs Pre-Market: CEO's Early Anniversary Post Has Retail Bulls Buzzing About Major News - Yahoo Finance | SLS Stock Climbs Pre-Market: CEO's Early Anniversary Post Has Retail Bulls Buzzing About Major News Yahoo Finance | View source ↗ | Yahoo Finance | Oct 19, 2026 | neutral | 0 | 0.6 |
| Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus - TradingView | Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus TradingView | View source ↗ | TradingView | Oct 19, 2026 | neutral | 0 | 0.6 |
| Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus - Yahoo Finance | Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus Yahoo Finance | View source ↗ | Yahoo Finance | Oct 19, 2026 | neutral | 0 | 0.6 |
| SLS Stock Logs 2-Day Losing Streak: Mixed Institutional Bets Emerge Ahead Of Key AML Trial Update - Stocktwits | SLS Stock Logs 2-Day Losing Streak: Mixed Institutional Bets Emerge Ahead Of Key AML Trial Update Stocktwits | View source ↗ | Stocktwits | Oct 19, 2026 | neutral | 0 | 0.6 |
| SLS Stock Logs Worst Week In Over A Month: Retail Bulls Bet ASH Embargo Is Keeping Regal Results Under Wraps - Yahoo Finance | SLS Stock Logs Worst Week In Over A Month: Retail Bulls Bet ASH Embargo Is Keeping Regal Results Under Wraps Yahoo Finance | View source ↗ | Yahoo Finance | Oct 19, 2026 | neutral | 0 | 0.6 |
| SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger - Stocktwits | SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger Stocktwits | View source ↗ | Stocktwits | Oct 17, 2026 | neutral | 0 | 0.6 |
| SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick - Stocktwits | SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick Stocktwits | View source ↗ | Stocktwits | Oct 17, 2026 | neutral | 0 | 0.6 |
| Sellas Life Sciences Group (Dinari Tokenized Stock) (SLS) Price Prediction for 2026 to 2031 - Bybit | Sellas Life Sciences Group (Dinari Tokenized Stock) (SLS) Price Prediction for 2026 to 2031 Bybit | View source ↗ | Bybit | Oct 17, 2026 | neutral | 0 | 0.6 |
| SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS - Stocktwits | SLS Stock Extends Rally Overnight: CEO Says ‘Bullish’ Leukemia Data Could Drive NCCN Recognition For GPS Stocktwits | View source ↗ | Stocktwits | Oct 17, 2026 | neutral | 0 | 0.6 |
| SLS Stock Slides As Pomerantz Probes Trial Disclosure - Timothy Sykes | SLS Stock Slides As Pomerantz Probes Trial Disclosure Timothy Sykes | View source ↗ | Timothy Sykes | Oct 16, 2026 | neutral | 0 | 0.6 |
| SLS Stock Sees Worst Day In Over A Month — But Prediction Market Flashes 83% Odds For November AML Trial Success - Stocktwits | SLS Stock Sees Worst Day In Over A Month — But Prediction Market Flashes 83% Odds For November AML Trial Success Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding War - Stocktwits | SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding War Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| SLS Stock Snaps 2-Day Slide: Sellas’ SLS009 AML Trial Spotlights Big Pharma Drug Combo From ABBV, RHHBY And BMY - Stocktwits | SLS Stock Snaps 2-Day Slide: Sellas’ SLS009 AML Trial Spotlights Big Pharma Drug Combo From ABBV, RHHBY And BMY Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout - Stocktwits | SLS Stock Rises Overnight: Traders Rally Behind Jim Cramer's 'Two Thumbs Up' Call Ahead Of Key AML Readout Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock Logs Best Day In Over A Week: JPMorgan Buys In And Stifel Boosts Bet Ahead Of Key AML Data - Stocktwits | SLS Stock Logs Best Day In Over A Week: JPMorgan Buys In And Stifel Boosts Bet Ahead Of Key AML Data Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock Logs Record H1 As AML Trial Nears Finish Line — Why Are Retail Traders Refusing To Cash Out? - Stocktwits | SLS Stock Logs Record H1 As AML Trial Nears Finish Line — Why Are Retail Traders Refusing To Cash Out? Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock Jumps Premarket: CEO Says GPS AML Data Has ‘Very Good Chance’ To Beat Earlier Survival Outcomes - Stocktwits | SLS Stock Jumps Premarket: CEO Says GPS AML Data Has ‘Very Good Chance’ To Beat Earlier Survival Outcomes Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock Climbs Premarket: Here’s What Smart Money Is Doing As Sellas Nears Critical Phase 3 AML Readout - Stocktwits | SLS Stock Climbs Premarket: Here’s What Smart Money Is Doing As Sellas Nears Critical Phase 3 AML Readout Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger - Stocktwits | SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| Sellas’ Experimental Drug SLS009 Appears To Be Leading The CDK9 Race, Says Alliance Global – Analyst Sees About 200% Upside Potential - Stocktwits | Sellas’ Experimental Drug SLS009 Appears To Be Leading The CDK9 Race, Says Alliance Global – Analyst Sees About 200% Upside Potential Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SLS Stock In Spotlight After Vanguard Capital Discloses 5.19% Stake – Retail Calls It ‘Huge Vote Of Conviction’ As AML Trial Readout Nears - Stocktwits | SLS Stock In Spotlight After Vanguard Capital Discloses 5.19% Stake – Retail Calls It ‘Huge Vote Of Conviction’ As AML Trial Readout Nears Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| SLS Stock Slips Overnight Ahead Of Pancreatic Cancer Conference — Retail Looks For Clues To SLS009’s Next Trial - Stocktwits | SLS Stock Slips Overnight Ahead Of Pancreatic Cancer Conference — Retail Looks For Clues To SLS009’s Next Trial Stocktwits | View source ↗ | Stocktwits | Oct 11, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.